Table 3.
Model | Nondemented, No. | AD, No. | MeDi Continuous OR (95% CI) | P Value | MeDi Tertiles OR (95% CI) | P for Trend | |
---|---|---|---|---|---|---|---|
1* | 1790 | 194 | 0.81 (0.74–0.88) | <.001 | Low | 1 (Reference) | <.001 |
Middle | 0.58 (0.42–0.81) | ||||||
High | 0.40 (0.26–0.61) | ||||||
2† | 1300 | 137 | 0.76 (0.67–0.87) | <.001 | Low | 1 (Reference) | <.001 |
Middle | 0.47 (0.29–0.76) | ||||||
High | 0.32 (0.17–0.59) | ||||||
3‡ | 1259 | 135 | 0.76 (0.66–0.86) | <.001 | Low | 1 (Reference) | <.001 |
Middle | 0.48 (0.29–0.79) | ||||||
High | 0.31 (0.16–0.58) |
Abbreviations: AD, Alzheimer disease; CI, confidence interval; MeDi, Mediterranean diet; OR, odds ratio.
Model 1 is unadjusted.
Model 2 is adjusted for cohort, age, sex, ethnicity, education, apolipoprotein E genotype, caloric intake, smoking, comorbidity index, and body mass index (calculated as weight in kilograms divided by height in meters squared).
Model 3 is adjusted for all variables of model 2 plus the following additional vascular variables: history of stroke, diabetes mellitus, hypertension, and heart disease and plasma levels of total cholesterol, high-density lipoprotein, triglycerides, and low-density lipoprotein.